Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.

Wood DE, Kazerooni E, Baum SL, Dransfield MT, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Leung AN, Makani SS, Massion PP, Meyers BF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Sequist LV, Tong BC, Travis WD, Yang SC, Gregory KM, Hughes M.

J Natl Compr Canc Netw. 2015 Jan;13(1):23-34; quiz 34.

PMID:
25583767
2.

Retrospective review of lung cancers diagnosed in annual rounds of CT screening.

Xu DM, Yip R, Smith JP, Yankelevitz DF, Henschke CI; I-ELCAP Investigators.

AJR Am J Roentgenol. 2014 Nov;203(5):965-72. doi: 10.2214/AJR.13.12115. Epub 2014 Sep 23. Review.

PMID:
25247825
3.

Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer.

Flores R, Bauer T, Aye R, Andaz S, Kohman L, Sheppard B, Mayfield W, Thurer R, Smith M, Korst R, Straznicka M, Grannis F, Pass H, Connery C, Yip R, Smith JP, Yankelevitz D, Henschke C, Altorki N; I-ELCAP Investigators.

J Thorac Cardiovasc Surg. 2014 May;147(5):1619-26. doi: 10.1016/j.jtcvs.2013.11.001. Epub 2013 Dec 9.

PMID:
24332102
4.

Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.

Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, Sheppard B, Thurer R, Andaz S, Smith M, Mayfield W, Grannis F, Korst R, Pass H, Straznicka M, Flores R, Henschke CI; I-ELCAP Investigators.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. doi: 10.1016/j.jtcvs.2013.09.065. Epub 2013 Nov 23.

PMID:
24280722
5.

Lung cancers diagnosed at annual CT screening: volume doubling times.

Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D, Smith JP, Libby DM, Pasmantier MW, Miettinen OS; Writing Committee for the I-ELCAP Investigators.

Radiology. 2012 May;263(2):578-83. doi: 10.1148/radiol.12102489. Epub 2012 Mar 27. Erratum in: Radiology. 2012 Jul;264(1):306.

6.

Lung cancer screening.

Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, Klippenstein D, Lackner RP, Leard L, Leung AN, Massion PP, Meyers BF, Munden RF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Schabath MB, Sequist LV, Tong BC, Travis WD, Unger M, Yang SC.

J Natl Compr Canc Netw. 2012 Feb;10(2):240-65. No abstract available.

PMID:
22308518
7.

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.

Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA.

Cancer. 2010 Jan 1;116(1):84-92. doi: 10.1002/cncr.24704.

8.

Semiquantitative visual approach to scoring lung cancer treatment response using computed tomography: a pilot study.

Gottlieb RH, Kumar P, Loud P, Klippenstein D, Raczyk C, Tan W, Lu J, Ramnath N.

J Comput Assist Tomogr. 2009 Sep-Oct;33(5):743-7. doi: 10.1097/RCT.0b013e3181963b14.

PMID:
19820504
9.

Malignant pleural mesothelioma after household exposure to asbestos.

Patel AV, Bogner PN, Klippenstein D, Ramnath N.

J Clin Oncol. 2008 Nov 20;26(33):5480-3. doi: 10.1200/JCO.2008.18.8268. Epub 2008 Oct 27. No abstract available.

10.

Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.

Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH.

J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8.

PMID:
17882021
11.

Preoperative imaging for metastasectomy.

Klippenstein DL, Lamonica DM.

Surg Oncol Clin N Am. 2007 Jul;16(3):471-92, vii.

PMID:
17606189
12.

Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment.

Loewen G, Natarajan N, Tan D, Nava E, Klippenstein D, Mahoney M, Cummings M, Reid M.

Thorax. 2007 Apr;62(4):335-40. Epub 2006 Nov 13.

13.

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL).

Chanan-Khan A, Miller KC, Takeshita K, Koryzna A, Donohue K, Bernstein ZP, Mohr A, Klippenstein D, Wallace P, Zeldis JB, Berger C, Czuczman MS.

Blood. 2005 Nov 15;106(10):3348-52. Epub 2005 Jul 28.

14.

Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.

Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH.

J Clin Oncol. 2005 Feb 1;23(4):694-704.

15.

Bimodality lung cancer screening in high-risk patients: a preliminary report.

Loewen G, Reid M, Tan D, Klippenstein D, Nava E, Natarajan R, Mahoney M.

Chest. 2004 May;125(5 Suppl):163S-4S. No abstract available.

PMID:
15136489
16.

The evolution of lung cancer screening.

Wilkinson NW, Loewen GM, Klippenstein DL, Litwin AM, Anderson TM.

J Surg Oncol. 2003 Dec;84(4):234-8. Review.

PMID:
14756435
17.

A Comparative Study of 511 keV SPECT and PET Using Separate 370 MBq F-18-FDG Doses on Different Days.

Lamonica D, Grossman Z, Klippenstein D, Wang H, Vilani J, Nabi HA.

Clin Positron Imaging. 1999 Mar;2(2):81-91.

PMID:
14516544
18.

Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).

Lamonica D, Czuczman M, Nabi H, Klippenstein D, Grossman Z.

Cancer Biother Radiopharm. 2002 Dec;17(6):689-97.

PMID:
12537673
19.

Combined CT venography and pulmonary angiography: a comprehensive review.

Katz DS, Loud PA, Bruce D, Gittleman AM, Mueller R, Klippenstein DL, Grossman ZD.

Radiographics. 2002 Oct;22 Spec No:S3-19; discussion S20-4. Review.

PMID:
12376597
20.

Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer.

Khushalani NI, Leichman CG, Proulx G, Nava H, Bodnar L, Klippenstein D, Litwin A, Smith J, Nava E, Pendyala L, Smith P, Greco W, Berdzik J, Douglass H, Leichman L.

J Clin Oncol. 2002 Jun 15;20(12):2844-50.

PMID:
12065561
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk